Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-14-071521)

Filing Details

Accession Number:: 0001104659-14-071521
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2014-10-14 13:03:22
Reporting Period:: 2014-10-09

Filing Date:: 2014-10-14
Accepted Time:: 2014-10-14 13:03:22
Original Submission Date:: 2014-10-10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
886163	Ligand Pharmaceuticals Inc	LGND	Pharmaceutical Preparations (2834)	770160744

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1442372	L Stephen Sabba	Dorset Management Corp 485 Underhill Blvd Suite 205 Syosset NY 11791		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-10-09	2,000	$43.12	23,697	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

These securities, as represented in Column 5, include a grant of 1,151 restricted shares issued by the Board of Directors of the Company at the Company's annual meeting of its shareholders on June 4, 2014, which shares will vest in full on the first anniversary of the grant date. The price set forth in Column 4 reflects the weighted average of two purchases of 1,000 each, one at $42.90 and one at $43.33.